The FDA has launched a safety study of the abortion pill, also called mifepristone, a step that could pave the way for the Trump administration to restrict how it is distributed and used, the Wall Street Journal reported on Thursday. The FDA has said mifepristone continues to be safe and effective for its intended purpose when used as directed. Reuters could not immediately verify the report. The FDA did not immediately respond to a Reuters request for comment outside regular office hours. In May, the U.S. Supreme Court ensured the abortion pill could continue to be prescribed through telemedicine and dispensed by mail when it restored a 2023 federal rule that had made access to the medication easier while a challenge brought by Republican-governed Louisiana made its way through the courts. The study, which has the White House’s backing, would use existing drug-safety systems, is expected to take six months and is intended to withstand legal criticism, the report said. The FDA is also
FDA launches study of abortion
Categories:
US positive on Iran deal but talks still uncertain as ceasefire end nearsUS positive on Iran deal but talks still uncertain as ceasefire end nears
The United States expressed confidence that peace talks with Iran would go ahead in Pakistan and a senior Iranian official said Tehran was considering joining, but significant hurdles and uncertainty
Crush at Gaza aid site kills at least 20, GHF blames armed agitatorsCrush at Gaza aid site kills at least 20, GHF blames armed agitators
At least 20 Palestinians were killed on Wednesday at an aid distribution site run by the Gaza Humanitarian Foundation (GHF), in what the U.S.-backed group said was a crowd surge
Canadian PM urges all parties in Iran war not to target civiliansCanadian PM urges all parties in Iran war not to target civilians
Canadian Prime Minister Mark Carney on Tuesday urged “all parties” in the Iran war not to target civilians following repeated threats made by U.S. President Donald Trump.“Canada expects all parties
